Kalbio Global Medika (KGM) is a biopharmaceutical company that focuses on bringing biologics medical innovation to markets outside US/Canada, Western Europe, and China. The company offers contract development and manufacturing services, including API manufacturing, formulation, and fill and finish capabilities. KGM is also involved in the manufacture of Efesa and has developed a pipeline of biosimilars and novel biologics. It is the first organization in Indonesia to be approved for production of commercial biotherapeutics.
Headquarters
Cicau, Kawasan Industri Delta Silicon 3, Blok F19 No. 2
Bekasi; West Java;
Postal Code: 17531
Contact Details: Purchase the PT Kalbio Global Medika report to view the information.
Website: http://www.kalbio.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service